• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期癌症感染患者抗生素使用与生存情况的回顾性分析

Retrospective analysis of antibiotic use and survival in advanced cancer patients with infections.

作者信息

Lam Po Tin, Chan Kin Sang, Tse Chun Yan, Leung Man Wai

机构信息

Division of Palliative Care, United Christian Hospital, Kowloon, Hong Kong.

出版信息

J Pain Symptom Manage. 2005 Dec;30(6):536-43. doi: 10.1016/j.jpainsymman.2005.06.005.

DOI:10.1016/j.jpainsymman.2005.06.005
PMID:16376740
Abstract

Infection is common among advanced cancer patients. This study was undertaken to review the pattern of use of antibiotics and to identify potential factors that could affect outcomes after infection. The medical records of all patients with advanced cancer who were enrolled into the palliative care service of a district hospital during the period January, 2002 to July, 2002 were retrospectively reviewed for infections and the use of antibiotics. Among the eligible 87 patients, 17 did not have any infective episode and 70 had at least one infective episode and accounted for a total of 120 episodes. Sixty-eight episodes were associated with survival for >14 days, and 52 episodes were associated with survival of < or =14 days. The most frequent sites of infection were chest (n=63, 52.5%), urinary tract (n=35, 29.2%), and skin/wound (n=6, 5%). Antibiotics were prescribed for 97.5% (n=117) episodes. The use of second-line antibiotics was 16.2% (n=19). By multivariate logistic regression analysis, dyspnea [odds ratio (OR)=2.6, 95% confidence interval (CI)=1.1-6.3], antibiotic utilization pattern [empirical therapy (OR=4.8, 95% CI=1.7-13.2) vs. therapy according to antibiotic sensitivity], and route of administration [parenteral route (OR=3.3, 95% CI=1.3-8.2) vs. oral route] were identified as independent determinants affecting survival after infection. Dyspnea was possibly associated with poor prognosis during the treatment of infections in patients with advanced cancer, and antibiotic therapy according to sensitivity was associated with better prognosis. Further studies are encouraged to verify this. The bioethical principles on the use of antibiotics as a life-sustaining treatment should always be followed.

摘要

感染在晚期癌症患者中很常见。本研究旨在回顾抗生素的使用模式,并确定可能影响感染后结局的潜在因素。对2002年1月至2002年7月期间纳入某地区医院姑息治疗服务的所有晚期癌症患者的病历进行回顾,以了解感染情况和抗生素使用情况。在符合条件的87例患者中,17例未发生任何感染事件,70例至少发生1次感染事件,共120次感染发作。68次发作与存活超过14天相关,52次发作与存活≤14天相关。最常见的感染部位是胸部(n = 63,52.5%)、尿路(n = 35,29.2%)和皮肤/伤口(n = 6,5%)。97.5%(n = 117)的发作使用了抗生素。二线抗生素的使用比例为16.2%(n = 19)。通过多因素逻辑回归分析,呼吸困难[比值比(OR)= 2.6,95%置信区间(CI)= 1.1 - 6.3]、抗生素使用模式[经验性治疗(OR = 4.8,95% CI = 1.7 - 13.2)与根据抗生素敏感性进行的治疗]以及给药途径[肠外途径(OR = 3.3,95% CI = 1.3 - 8.2)与口服途径]被确定为影响感染后存活的独立决定因素。呼吸困难可能与晚期癌症患者感染治疗期间的预后不良有关,而根据敏感性进行抗生素治疗与较好的预后相关。鼓励进一步研究以验证这一点。在使用抗生素作为维持生命治疗时,应始终遵循生物伦理原则。

相似文献

1
Retrospective analysis of antibiotic use and survival in advanced cancer patients with infections.晚期癌症感染患者抗生素使用与生存情况的回顾性分析
J Pain Symptom Manage. 2005 Dec;30(6):536-43. doi: 10.1016/j.jpainsymman.2005.06.005.
2
Presentation, treatment, and analysis of prognostic factors of terminally ill patients with gastrointestinal tumors.晚期胃肠道肿瘤患者的临床表现、治疗及预后因素分析
Onkologie. 2009 Jul;32(7):380-6. doi: 10.1159/000218355. Epub 2009 Jun 12.
3
Antibiotic use during the last days of life in cancer patients.癌症患者生命末期的抗生素使用情况。
Eur J Cancer Care (Engl). 2006 Mar;15(1):74-9. doi: 10.1111/j.1365-2354.2005.00603.x.
4
Morphine for dyspnea control in terminal cancer patients: is it appropriate in Taiwan?吗啡用于终末期癌症患者的呼吸困难控制:在台湾是否合适?
J Pain Symptom Manage. 2004 Oct;28(4):356-63. doi: 10.1016/j.jpainsymman.2004.01.004.
5
Occurrence and treatment of suspected pneumonia in long-term care residents dying with advanced dementia.晚期痴呆临终长期护理居民疑似肺炎的发生与治疗
J Am Geriatr Soc. 2006 Feb;54(2):290-5. doi: 10.1111/j.1532-5415.2005.00524.x.
6
The impact of palliative care on cancer deaths in Hong Kong: a retrospective study of 494 cancer deaths.姑息治疗对香港癌症死亡的影响:一项对494例癌症死亡病例的回顾性研究。
Palliat Med. 2007 Jul;21(5):425-33. doi: 10.1177/0269216307079825.
7
Dyspnea in cancer patients. Etiology, resource utilization, and survival-implications in a managed care world.癌症患者的呼吸困难。在管理式医疗环境下的病因、资源利用及生存影响。
Cancer. 1996 Sep 15;78(6):1314-9. doi: 10.1002/(SICI)1097-0142(19960915)78:6<1314::AID-CNCR21>3.0.CO;2-2.
8
Impact of infections on the survival of hospitalized advanced cancer patients.感染对住院晚期癌症患者生存的影响。
J Pain Symptom Manage. 2012 Mar;43(3):549-57. doi: 10.1016/j.jpainsymman.2011.04.010. Epub 2011 Nov 8.
9
A second look at anorectal infections in cancer patients in a large cancer institute: the success of early intervention with antibiotics and surgery.大型癌症研究所对癌症患者肛门直肠感染的再审视:抗生素与手术早期干预的成效
Infection. 2002 Oct;30(5):272-6. doi: 10.1007/s15010-002-2197-8.
10
The pattern of antimicrobial use for palliative care in-patients during the last week of life.临终前一周姑息治疗住院患者的抗菌药物使用模式。
Am J Hosp Palliat Care. 2012 Feb;29(1):60-3. doi: 10.1177/1049909111406900. Epub 2011 Jun 15.

引用本文的文献

1
End-of-Life Infections and the Dilemma of Emerging Antimicrobial Resistance: A Scoping Review.临终感染与新出现的抗菌药物耐药性困境:一项范围综述
Infect Chemother. 2025 Mar;57(1):1-12. doi: 10.3947/ic.2024.0088.
2
Current trends in antimicrobial use and the role of antimicrobial stewardship in palliative oncology: a narrative review.姑息性肿瘤学中抗菌药物使用的当前趋势及抗菌药物管理的作用:一篇叙述性综述
BMC Palliat Care. 2025 Jan 16;24(1):15. doi: 10.1186/s12904-025-01649-x.
3
Antibiotic Use at the End of Life: Current Practice and Ways to Optimize.
临终时的抗生素使用:当前实践与优化方法
Am J Hosp Palliat Care. 2025 Jun;42(6):610-615. doi: 10.1177/10499091241266986. Epub 2024 Jul 19.
4
Antibiotic Treatment in End Stage Cancer Patients; Advantages and Disadvantages.晚期癌症患者的抗生素治疗:利弊
Cancer Inform. 2023 Mar 29;22:11769351231161476. doi: 10.1177/11769351231161476. eCollection 2023.
5
Prospective Evaluation of Intensity of Symptoms, Therapeutic Procedures and Treatment in Palliative Care Patients in Nursing Homes.养老院姑息治疗患者症状强度、治疗程序及治疗的前瞻性评估
J Clin Med. 2020 Mar 10;9(3):750. doi: 10.3390/jcm9030750.
6
Design and analysis of longitudinal trials of antimicrobial use at the end of life: to give or not to give?临终时抗菌药物使用纵向试验的设计与分析:用还是不用?
Ther Adv Drug Saf. 2019 Feb 8;10:2042098618820210. doi: 10.1177/2042098618820210. eCollection 2019.
7
Variations in Physician Orders for Life-Sustaining Treatment Program across the Nation: Environmental Scan.全国范围内医师生命维持治疗方案医嘱的差异:环境扫描。
J Palliat Med. 2019 Sep;22(9):1032-1038. doi: 10.1089/jpm.2018.0626. Epub 2019 Feb 21.
8
Antimicrobial Use in Patients on a Comfort Care Protocol: A Retrospective Cohort Study.临终关怀方案下患者的抗菌药物使用:一项回顾性队列研究
J Palliat Med. 2016 Nov;19(11):1210-1214. doi: 10.1089/jpm.2016.0094. Epub 2016 Jun 16.
9
Decision making about change of medication for comorbid disease at the end of life: an integrative review.临终时合并症用药调整的决策制定:一项综合综述。
Drugs Aging. 2014 Jul;31(7):501-12. doi: 10.1007/s40266-014-0182-4.
10
Antimicrobial use for symptom management in patients receiving hospice and palliative care: a systematic review.接受临终关怀和姑息治疗患者的症状管理中的抗菌药物使用:系统评价。
J Palliat Med. 2013 Dec;16(12):1568-74. doi: 10.1089/jpm.2013.0276. Epub 2013 Oct 23.